Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

Capivasertib: Scientists hail ‘landmark moment’ as drug slows growth of breast cancer

A screening for breast cancer (Stock image)

(Picture: PA Archive)

Scientists have hailed a “landmark moment” in the treatment of advanced breast cancer after a new drug was shown to slow the growth of the disease.

Capivasertib was found to double the amount of time people have the disease before it progresses in a clinical trial, potentially benefitting up to 8,000 women every year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.